The single most important fact about memory care in Pennsylvania, and the one most national content gets wrong, is that "memory care" in PA is not a license. It is a clinical and operational concept that exists inside one of three separately licensed settings: a Personal Care Home with a Secured Dementia Care Unit (SCU) under 55 Pa. Code §§ 2600.231 to 2600.239, an Assisted Living Residence with a Secured Dementia Care Unit under 55 Pa. Code §§ 2800.231 to 2800.239, or a nursing facility dementia unit operated within an existing 28 Pa. Code Chapter 201 license. Different bureaus license each setting (DHS BHSL for PCH, DHS OLTL for ALR, DOH for nursing facilities). Different rules govern staffing, training, aging in place, physical plant, and discharge. Different funding sources pay each one. Knowing which underlying license you are dealing with is the single most consequential decision a PA family can make about memory care, because it determines what the unit must legally do for your parent, what it costs, and whether Medicaid will ever pay.

Pennsylvania has roughly 282,000 residents 65 and older living with Alzheimer's disease in 2026 per the Alzheimer's Association's 2026 Facts and Figures, supported by approximately 472,000 family caregivers contributing about 835 million hours of unpaid care valued at $17.2 billion. PA Medicaid spending on Alzheimer's-related care runs about $4.6 billion per year. About 95 percent of PA "memory care" beds sit inside Personal Care Homes with Secured Dementia Care Units, which are private-pay settings PA Medicaid does not cover. The other roughly 5 percent sit inside the smaller and more premium Assisted Living Residence inventory (also private-pay). Nursing facility dementia units are the only memory-care setting in PA where Medicaid actually pays the bill, through Community HealthChoices for adults 21+ at NF clinical level of care. This guide walks through how the three settings actually work, what each costs in 2026, where the funding comes from, the Lewy body antipsychotic safety issue that is the largest dementia-specific quality risk in PA, the new Alzheimer's, Dementia and Related Disorders Office created by Act 111 of 2024, and how to evaluate a memory-care community before signing the admission agreement.

By Brevy Care Team

  • "Memory care" is not a Pennsylvania license. It is a clinical concept delivered inside a PCH SCU (DHS BHSL, ~95% of PA memory-care beds), an ALR SCU (DHS OLTL, ~5%), or a nursing facility dementia unit (DOH).
  • PA Medicaid does NOT pay for PCH or ALR memory care. There is no PA assisted-living Medicaid waiver. The only Medicaid-covered memory care is the nursing facility dementia unit, paid through CHC for adults 21+ at NF clinical level of care.
  • Median 2026 PA cost: PCH memory care $5,500 to $8,000 per month; ALR memory care $7,500 to $10,000+; NF dementia unit $10,400 to $12,800 private (Medicaid covers the difference once eligible).
  • PCH SCU and ALR SCU staffing minimums are set by §§ 2600.231 and 2800.231, materially stricter than general PCH and ALR requirements. NF dementia units have no separate state license for dementia.
  • PA SCU direct-care staff must complete dementia-specific training before working unsupervised in the SCU, with ongoing annual continuing education under §§ 2600.65 and 2800.65. The best PA SCUs train far above the regulatory minimum.
  • Lewy body and Parkinson's-related dementia residents have severe antipsychotic sensitivity. Quetiapine and pimavanserin are the typical safe choices; haloperidol, olanzapine, and risperidone can be dangerous or fatal in this population.
  • Act 111 of 2024 created PA's first Alzheimer's, Dementia and Related Disorders (ADRD) Office in the Department of Aging, effective ~April 14, 2025. Contact: ADRDoffice@pa.gov, (717) 783-1550.

Memory Care Is Not a License, It Is a Clinical Concept Inside Three Different License Types

The first question on a memory-care tour in PA should be "What license does this unit operate under, and which DHS or DOH bureau inspects it?" The answer determines almost everything else.

A Personal Care Home with a Secured Dementia Care Unit is licensed by the PA Department of Human Services Bureau of Human Services Licensing (BHSL) under 55 Pa. Code Chapter 2600, with the SCU subchapter at sections 2600.231 to 2600.239. The PCH SCU framework was finalized in the comprehensive 2005 Chapter 2600 rewrite. About 95 percent of PA memory-care beds sit in PCH SCUs.

An Assisted Living Residence with a Secured Dementia Care Unit is licensed by the PA Department of Human Services Office of Long-Term Living (OLTL) under 55 Pa. Code Chapter 2800, with the SCU subchapter at sections 2800.231 to 2800.239. The ALR license was created by Act 56 of 2007 and the regulations took effect January 18, 2011. ALR SCUs are roughly 5 percent of PA memory-care beds and are concentrated in southeastern PA and the Pittsburgh metro.

A nursing facility dementia unit is licensed by the PA Department of Health, Bureau of Long-Term Care, under 28 Pa. Code Chapter 201 and Chapter 211. There is NO separate state license category for "nursing facility dementia unit." Dementia care quality inside NFs is regulated through the federal F-tag survey framework under 42 CFR Part 483 (specifically F744 Quality of Care for Residents with Dementia, F758 Psychotropic Medications, and F605 Chemical Restraint), not through a state-level dementia-unit license.

The consequences of which license you are looking at:

  • Different staffing minimums. PCH SCU and ALR SCU both require enhanced staffing minimums under §§ 2600.231 and 2800.231, materially stricter than their general-unit counterparts. NF dementia units have no separate regulatory ratio; they bind to the general direct-care floor under 28 Pa. Code Chapter 211.
  • Different aging-in-place rules. ALR SCUs have a Chapter 2800 aging-in-place mandate; the resident can remain through Supplemental Health Care Services as needs increase. PCH SCUs do not, and the 14-day bedfast cap and Stage III/IV pressure ulcer prohibition force PCH SCU residents into NFs as their disease progresses. NFs accommodate end-of-life care.
  • Different physical-plant standards. ALR SCU residents are still entitled to a private apartment of at least 250 square feet single or 350 square feet double under Chapter 2800, with private bath and (commonly waived in SCUs) kitchenette. PCH SCU residents may share rooms with up to four occupants in pre-2005 buildings or two occupants in newer construction. NF dementia residents are typically in semi-private rooms unless they pay private-pay for an upgrade.
  • Different Medicaid coverage. PCH SCU and ALR SCU are private-pay for nearly all residents. NF dementia care is covered by PA Medical Assistance Long-Term Care through CHC for adults 21+ who meet NF clinical and financial eligibility.
  • Different inspection portal. PCH and ALR SCU inspections post to PA COMPASS at compass.state.pa.us. NF inspections post to CMS Care Compare at medicare.gov/care-compare and PA DOH Nursing Home Reports.

The Personal Care Home Secured Dementia Care Unit

A PCH SCU operates within an existing PCH license under 55 Pa. Code Chapter 2600. The SCU subchapter at sections 2600.231 to 2600.239 is triggered when a PCH operates a unit that is held out as serving residents with dementia, restricts free egress (locked door, keypad, alarmed exit, magnetic delayed-egress lock), or charges a different rate for residents in that unit. Any of those three triggers brings the SCU rules.

Physical plant standards under section 2600.231(b) require a controlled-egress system consistent with NFPA 101 Life Safety Code (typically a 15-second delayed-egress magnetic lock), way-finding design (color-contrasted bathroom doors, name plus photograph on each resident's room door, elimination of dead-end corridors), and access to a secure outdoor space. Best practice memory-care designs include circular wandering paths, raised garden beds, shaded seating, sensory plantings, and water features. Many newer builds include a multi-sensory snoezelen room.

Staffing under section 2600.231 requires enhanced staffing minimums, materially stricter than the general PCH ratio. The SCU staffing differential is the single most consequential operational difference between general PCH care and PCH memory care, and it is the largest reason the SCU premium runs $1,000 to $2,500 above the general PCH base rate. An awake direct-care staff person must be present in the unit 24 hours; no PCH SCU may operate with a single sleeping staff member.

Training under sections 2600.231(c) and 2600.65 requires SCU direct-care staff to complete dementia-specific training before working unsupervised in the SCU and ongoing dementia-specific continuing education annually. The general PCH dementia-training requirement under § 2600.65 is 6 hours annually. SCU direct-care staff receive additional training on top of that general floor. The highest-quality PA SCUs train substantially above the regulatory minimum, often through Teepa Snow's Positive Approach to Care (PAC), Naomi Feil's Validation Therapy, Music & Memory certification, or Montessori-Based Dementia Programming.

Every PCH SCU must give each prospective resident or representative a written SCU Disclosure form that documents the unit's philosophy of dementia care, admission and discharge criteria, staffing pattern, training, programming, family involvement policies, and cost structure (base rate, SCU premium, ancillary charges, level-of-care upcharges). The SCU Disclosure is the single most useful document for a family touring a PA memory-care community. Always request it before signing the admission agreement. If the facility cannot produce one, that is a red flag and likely a regulatory deficiency.

Admission requires a documented diagnosis of Alzheimer's disease or another irreversible dementia and a determination that the SCU can meet the resident's needs. Retention is bounded by the standard PCH retention thresholds (no 14-day bedfast without DHS-approved plan, no Stage III or IV pressure ulcers, no continuous skilled nursing) plus the SCU-specific limit that the unit may discharge if behavioral acuity exceeds what non-pharmacological interventions and physician-ordered psychotropic medications can safely manage.

The Assisted Living Residence Secured Dementia Care Unit

An ALR SCU operates within an existing ALR license under 55 Pa. Code Chapter 2800. The SCU subchapter at sections 2800.231 to 2800.239 mirrors the PCH SCU triggers. The single largest difference between PCH and ALR memory care is physical plant: Chapter 2800's private-apartment standard (at least 250 square feet single or 350 square feet double, kitchenette, private bath, lockable door) continues to apply to SCU residents, with two practical accommodations. First, DHS routinely grants waivers of the kitchenette requirement in SCUs because in-unit cooking surfaces and refrigerators present safety risks for residents with advanced dementia. The kitchenette waiver is the most commonly granted Chapter 2800 waiver in practice. Second, the lockable-door requirement persists but with staff override capacity from outside in an emergency.

Staffing under section 2800.231 sets enhanced minimums, with the binding constraint on the sleep-side ratio, which is materially stricter than the general ALR sleep ratio. Training under § 2800.65 builds on a general ALR dementia training floor that is higher than the general PCH requirement of 6 hours annually under § 2600.65. ALR SCU staff therefore typically have more cumulative dementia training than PCH SCU staff because they enter their role from a higher baseline.

The decisive feature of ALR memory care is the aging-in-place mandate at Chapter 2800. As the resident's dementia progresses, the ALR has an affirmative obligation to support continued residence through Supplemental Health Care Services (SHCS) under section 2800.142, including skilled nursing, hospice, sliding-scale insulin, wound care, and tube feeding delivered by the ALR or its contracted licensed providers. Where a PCH SCU would discharge a resident who reached the 14-day bedfast threshold or developed a Stage III pressure ulcer, an ALR SCU can retain that resident through end of life via contracted hospice. ALR SCU is the most clinically equipped non-NF setting available in PA, and that capacity is what drives the cost premium of typically $1,500 to $3,000 per month over a comparable PCH SCU.

ALR SCU admission requires a documented dementia diagnosis and a determination that the ALR can meet the resident's needs (with SHCS as needed). Discharge happens only when the resident's needs cannot be safely met even with SHCS in place, for example, continuous ventilator dependence or full-time skilled nursing that exceeds contracted capacity.

The Nursing Facility Dementia Unit

PA does not issue a separate "nursing facility dementia unit" license. A NF dementia unit is an operational designation inside an existing 28 Pa. Code Chapter 201 NF license, typically a physically secured wing of a larger nursing facility staffed and programmed for residents with mid-to-advanced dementia. The federal regulatory framework at 42 CFR Part 483 governs dementia care quality inside the unit, principally through the F-tag survey system.

The dementia-relevant F-tags every PA NF must answer to:

  • F744 (Quality of Care for Residents with Dementia) under 42 CFR § 483.40(b)(3). Requires the facility to ensure dementia residents receive appropriate treatment and services to attain or maintain their highest practicable physical, mental, and psychosocial well-being. Survey guidance covers care planning, behavioral interventions, environmental factors, and prevention of harm.
  • F758 (Psychotropic Medications) under 42 CFR § 483.45(c)(3) and (e)(1) to (5). Requires documented clinical indication, targeted behavior identification, non-pharmacological interventions tried first, initial and ongoing monitoring, and Gradual Dose Reduction (GDR) attempts twice in the first year and annually thereafter unless clinically contraindicated. Antipsychotics in dementia get extra scrutiny under the FDA black-box warning for atypical antipsychotics in elderly dementia patients.
  • F605 (Chemical Restraint) under 42 CFR § 483.12(a)(2). Prohibits psychotropic medications used for "discipline, convenience, or any purpose not required to treat the resident's medical symptoms." Frequently cited alongside F758 in dementia survey findings.
  • F600 (Abuse and Neglect) under 42 CFR § 483.12. Dementia residents are a high-risk subgroup because of communication impairments.
  • F689 (Free from Accidents) under 42 CFR § 483.25(d). Falls, elopement, choking, and wandering injuries get scrutinized.
  • F622 (Transfer and Discharge). Frequently cited in "hospital dump" cases where a NF refuses to readmit a dementia resident after hospitalization.

The binding state-level staffing constraint is 28 Pa. Code Chapter 211. The federal CMS Minimum Staffing Rule (CMS-3442-F) was repealed effective February 2, 2026, but the federal repeal does not lower PA's state-level floor. Operationally, PA NF dementia units typically run 1:6 day, 1:8 evening, 1:10 night, exceeding the general 28 Pa. Code Chapter 211 staffing on day and evening shifts because dementia care is acuity-intensive.

The CMS National Partnership to Improve Dementia Care, launched 2012, has substantially reduced the national long-stay antipsychotic prescribing rate in nursing facilities over the past decade.

PA Medicaid pays NF dementia care through Community HealthChoices for adults 21+ at NF clinical and financial eligibility. The CHC MCO contracts with the facility and pays per-diem. PA's NF reimbursement uses a case-mix adjustment that captures higher acuity for dementia residents. Critically, PA Medicaid does NOT pay an explicit "SCU premium" for placement in a dementia unit; the case-mix adjustment is the only mechanism by which higher dementia acuity flows to higher per-diem reimbursement.

The 2026 Cost Picture

Setting Base Monthly Rate SCU/Memory Care Premium Typical Total Monthly Cost
PCH memory care (PCH SCU) $4,500–$5,500 $1,000–$2,500 $5,500–$8,000
ALR memory care (ALR SCU) $5,500–$7,000 $1,000–$2,500 $7,500–$10,000+
NF dementia unit (private pay) Varies by region and setting $500–$1,500 $10,400–$12,800
LIFE Program (PACE) Capitated None $0 to participant if MA-eligible

Regional variation across PA is significant. PCH SCUs run roughly $7,000 to $9,000+ per month in southeastern PA (Main Line, Bucks, Chester, Delaware, Montgomery), $6,500 to $8,500 in the Pittsburgh metro, $6,500 to $8,000 in the Lehigh Valley, $5,500 to $7,000 in the Capital region (Harrisburg, Lancaster, York), $5,000 to $6,500 in Erie and northwestern PA, and $4,500 to $6,000 in rural Central and Northern Tier counties. ALR memory care is concentrated in southeastern PA and the Pittsburgh metro, where premium product can reach $11,000 to $13,000 per month. Rural PA has very few ALR SCU options; most rural PA "memory care" is PCH SCU.

Genworth (now CareScout after a 2024 rebrand) publishes the most-cited industry cost data, but the survey tends to underweight the SCU premium. PA market reporting typically runs 5 to 10 percent above the Genworth headline numbers when SCU premium is accounted for honestly. PA NF private-room rates vary significantly by region; a $500 to $1,500 SCU premium is typical, putting total NF dementia unit costs in the $10,400 to $12,800 range before ancillary charges.

Common ancillary charges across all three settings include level-of-care upcharges as ADL needs increase, beauty and barber, transportation to non-medical appointments, escort services, private 1:1 sitters ($25 to $40 per hour), specialty diets, telephone, cable upgrade, and incontinence supplies in some facilities. Always ask for a written list of base-covered services and a written list of typical ancillary charges before signing. ALR SCUs frequently bill SHCS separately or use a tiered acuity rate as the resident's clinical needs progress.

Funding Sources for PA Memory Care

This is the single most consequential financial reality for PA dementia families and the one most national content gets wrong.

PA Medicaid pays for nursing facility dementia care, not PCH or ALR memory care. Pennsylvania does not operate a 1915(c) HCBS waiver, 1915(i) state plan benefit, or 1115 demonstration that pays for assisted-living-bundled services in a PCH or ALR. There is no AL/MC Medicaid waiver in PA. PCH SCU and ALR SCU are private-pay settings for nearly all residents. The only Medicaid pathways for dementia care in PA are (a) NF dementia unit placement once the resident meets clinical and financial eligibility, paid through CHC, or (b) home and community-based services through CHC or the LIFE Program for community-dwelling dementia residents.

For PCH SCU and ALR SCU funding, the toolbox is private. The Personal Care Home Supplement (PCHS) is a small SSI add-on for low-income PCH residents, far below most PCH SCU rates and not a meaningful memory-care funding source for most families. Long-term care insurance with a cognitive-impairment trigger (defined per the HIPAA standard: impairment in short-term or long-term memory, orientation, or reasoning sufficient to require substantial supervision to protect the insured from threats to health or safety) typically begins paying in moderate dementia (GDS 4-5), and the cognitive trigger does not require an ADL deficit. Hybrid life/LTC policies (Asset Care, OneAmerica) work the same way, accelerating the death benefit to fund LTC.

VA Aid and Attendance is an underused funding source for dementia families with a wartime-veteran connection. The 2026 maximum benefits run approximately $2,422 per month for a single veteran, $2,871 for a married veteran, and $1,556 for a surviving spouse. The service requirement is 90 days of active duty with at least one day in a wartime period (WWII, Korea, Vietnam, Gulf War from August 2, 1990 to present). For a married veteran, the A&A benefit can cover roughly 35 to 50 percent of a typical PA PCH SCU rate. PA Veterans Service Officers at the county level help with the application; the PA Department of Military and Veterans Affairs operates six State Veterans' Homes, some with dementia units.

The PA Caregiver Support Program (CSP), expanded by Act 20 of 2021, reimburses out-of-pocket caregiving expenses up to approximately $600 per month for primary caregivers of cognitively-impaired adults plus a $5,000 lifetime home-modification cap. CSP is administered through the 52 Area Agencies on Aging and reached through the PA Link line at 1-800-753-8827. It does not pay PCH/ALR SCU rates directly but can subsidize in-home support before placement (adult day fees, in-home aide hours, GPS trackers, door alarms, MedicAlert subscription, grab bars, ramps).

The LIFE Program is PA's PACE branding and serves a meaningful share of community-dwelling dementia residents through its interdisciplinary team model, day-center programming, and in-home wraparound. LIFE participants pay $0 if MA-eligible. LIFE does not pay for PCH or ALR SCU placement, but it can substantially extend the time before residential placement is needed.

PA OPTIONS Program is a state-funded HCBS supplement administered through the AAAs for older adults age 60+ who do not qualify for CHC waiver but need home and community services (in-home personal care, adult day, home-delivered meals, transportation). OPTIONS uses sliding cost-share by income and is not strictly tied to MA financial eligibility.

A properly-documented Personal Care Agreement (a written contract under which an adult child or other family member is paid for caregiving services to a parent with dementia) can preserve Medicaid eligibility while compensating the caregiver, but must use an arms-length pay rate, written services description, and W-2 or 1099 reporting to avoid Medicaid 5-year lookback recharacterization or PA inheritance-tax recharacterization. This is not a DIY area; an elder-law attorney should draft the agreement.

Care Progression and Staging, When Memory Care Becomes Appropriate

Dr. Barry Reisberg's Global Deterioration Scale (GDS, 1982) and Functional Assessment Staging Tool (FAST, 1988) are the most widely used staging tools for Alzheimer's disease and related dementias, and they remain the framework PA memory-clinic teams use to translate a clinical diagnosis into a placement decision.

Stages 1 to 3 (no cognitive decline through mild cognitive impairment) are pre-dementia. Family typically pursues memory-clinic evaluation and lifestyle interventions (vascular risk-factor management, cognitive engagement, sleep, exercise, social connection). FDA-approved disease-modifying anti-amyloid therapies (lecanemab, donanemab) are increasingly available at PA academic centers (Penn Memory Center, Pitt ADRC, Penn State Health Hershey, AHN, Geisinger) for early-stage Alzheimer's.

Stage 4 (mild dementia) brings difficulty with complex tasks (finances, travel planning, hosting). Family typically begins exploring in-home support, adult day, and the CMS GUIDE Model dementia-care navigation benefit if the person is on Original Medicare.

Stage 5 (moderate dementia) brings the need for help selecting clothing, occasional disorientation to place or time, and increasing safety concerns. Memory care placement typically becomes appropriate at Stage 5, especially if caregiver burden is high, the home environment cannot be made safe (wandering risk, stove safety), or behavioral acuity is challenging.

Stage 6 (moderately severe dementia) brings ADL dependence (dressing, bathing, toileting), loss of recognition of close family, and personality changes including agitation or sleep-wake disturbance. Memory care or a NF dementia unit is appropriate depending on continence, ambulation, and behavioral acuity.

Stage 7 (severe dementia) brings progressive loss of language, ambulation, and ultimately the ability to sit up, smile, or hold up the head. NF dementia unit care is typical, and the resident is eligible for the Medicare hospice benefit at FAST 7c or beyond plus a comorbid condition (aspiration pneumonia, Stage 3-4 pressure ulcer, urosepsis, weight loss > 10 percent, recurrent fevers, or a prognosis of 6 months or less).

Common triggers PA Alzheimer's Association staff and memory-clinic social workers cite as the practical signal that home care is no longer safe: wandering or elopement risk, repeated unattended cooking incidents, medication errors, sundowning that erodes the primary caregiver's sleep, falls (especially with injury), incontinence beyond family capacity, physical aggression toward a spouse, and resistance to bathing, food, or fluids. Counter-indicators (when home care can continue safely) include stable disease in early-to-mid stage, moderate caregiver burden with adequate in-home support, active GUIDE Model navigation, adult day covering daytime hours, LIFE enrollment, and an explicit family preference to remain at home with hospice eventually.

The Lewy Body Antipsychotic Safety Issue

This is the single largest dementia-specific safety concern in PA memory care, and it is the issue national content most often gets wrong.

Residents with Lewy body dementia (DLB) and Parkinson's-related dementia have severe sensitivity to typical and many atypical antipsychotic medications. Haloperidol, olanzapine, and risperidone can trigger neuroleptic sensitivity reactions including muscle rigidity, fever, autonomic instability, and death. Lewy body dementia accounts for roughly 5 percent of all dementia cases and is often initially misdiagnosed as Alzheimer's, especially when the hallmark visual hallucinations, fluctuating cognition, REM sleep behavior disorder, and parkinsonism present asymmetrically.

Quetiapine (Seroquel) and pimavanserin (Nuplazid, FDA-approved 2016 specifically for Parkinson's disease psychosis) are the two antipsychotics generally considered acceptable in LBD when antipsychotic medication is clinically necessary. Both still require careful F758-compliant prescribing with documented non-pharmacological interventions tried first, targeted behavior identification, initial and ongoing monitoring, and Gradual Dose Reduction attempts twice in the first year and annually thereafter unless clinically contraindicated.

For PA families: if your parent's diagnosis is Lewy body dementia, Parkinson's-related dementia, or any dementia where Lewy body pathology is suspected (visual hallucinations early, fluctuating cognition, REM sleep behavior disorder, parkinsonism), confirm with the SCU before admission that staff understand the LBD antipsychotic sensitivity, that the resident's neurology team is in the loop on any prescribing decisions, and that the unit's protocol prefers quetiapine or pimavanserin over haloperidol, olanzapine, or risperidone. Monitor for neuroleptic sensitivity reactions in the first one to two weeks after any new antipsychotic medication.

A PCH SCU or NF dementia unit with a high antipsychotic prescribing rate (above 25 percent for long-stay residents on Care Compare's QM domain) and a Lewy body resident is a serious quality concern. Ask the question explicitly on tour: "What percentage of your residents are on a regular antipsychotic medication, and what is your protocol when a Lewy body or Parkinson's-related dementia resident develops behavioral symptoms?"

The Other Dementia Diagnoses, Why They Matter for Care Planning

Alzheimer's disease accounts for 60 to 80 percent of dementia cases and is the most extensively studied subtype for memory-care programming (reminiscence, validation, music, sensory therapy). FDA-approved anti-amyloid therapies for early-stage Alzheimer's are increasingly available at PA academic centers.

Vascular dementia is 10 to 20 percent of cases, often co-occurring with Alzheimer's as "mixed dementia." Care planning emphasizes aggressive vascular risk-factor management (blood pressure, A1c, lipids, atrial fibrillation anticoagulation) and surveillance for transient ischemic attacks and strokes.

Frontotemporal dementia (FTD) runs 5 to 10 percent of younger-onset dementia (typical onset 45 to 65, younger than Alzheimer's). The behavioral variant brings disinhibition, apathy, loss of empathy, compulsive behaviors, and hyperorality, which present major behavioral management challenges in standard memory care. PCH SCUs and even some ALR SCUs may decline FTD admissions because behavioral acuity exceeds capacity. Specialized FTD-experienced memory care exists at a small number of PA facilities; ask explicitly.

Reversible dementia mimics must be ruled out before placement: vitamin B12 deficiency, thyroid disease, normal pressure hydrocephalus, depression with pseudodementia, anticholinergic or benzodiazepine side effects, subdural hematoma, hypoglycemia or hyperglycemia, urinary tract infection, and other systemic infections. A primary-care "dementia diagnosis" without specialist workup is insufficient justification for SCU placement. A comprehensive memory-clinic evaluation at Penn, Pitt, Geisinger, Penn State Health Hershey, AHN, Jefferson, Temple, Lehigh Valley Health Network, Reading/Tower Health, or WellSpan screens for these.

The Pennsylvania Alzheimer's Policy Architecture

The PA Alzheimer's Disease and Related Disorders Act of 2014 directed the PA Department of Aging to convene the PA Alzheimer's Disease Planning Committee and publish a PA Alzheimer's State Plan. The first plan was published in 2014.

Act 9 of 2022 (Alzheimer's Early Detection and Diagnosis Act) directed PA DOH to maintain a primary-care-provider information page on early detection of Alzheimer's disease and related dementias.

Act 111 of 2024 (Alzheimer's, Dementia and Related Disorders Act) is the centerpiece of the current PA dementia policy architecture. Originally Senate Bill 840 of the 2023-24 session, it was signed by Governor Shapiro on October 16, 2024 and took effect approximately April 14, 2025. Act 111 created PA's first-ever Alzheimer's, Dementia and Related Disorders (ADRD) Office within the PA Department of Aging, with a $1.9 million initial appropriation and an ADRD Advisory Committee charged with coordinating dementia services across state agencies, AAAs, academic medical centers, advocacy organizations, and consumer representatives. The ADRD Office is also charged with refreshing the PA Alzheimer's State Plan. Office contact: ADRDoffice@pa.gov, (717) 783-1550. The office hosts the Reimagine ADRD Symposium series.

Act 61 of 2023 and follow-on 2025 guardianship reform legislation tighten the standards for adult guardianship and require courts to consider less-restrictive alternatives, which is meaningful for dementia families weighing guardianship versus durable power of attorney. The strong recommendation is to execute the Health Care POA, Financial POA, Living Will, and HIPAA authorization while the person with dementia still has legal capacity.

How to Choose a PA Memory Care Community

The single most actionable tour question is "What is your annual SCU staff turnover, and what percentage of your SCU shifts in the last 30 days were filled by agency staff?" Industry average for memory care is 60 to 80 percent annual turnover; sub-50 percent is exceptional. High agency utilization (above 20 percent) is a quality red flag. A stable staff knows residents' personalities, behavioral triggers, and family relationships, and consistently delivers higher-quality care.

The full tour checklist:

  • "What license type is this unit, PCH (BHSL) or ALR (OLTL)? May I see the SCU Disclosure form?"
  • "What is the SCU staffing ratio on day, evening, and night shifts? What is your annual SCU staff turnover? What percentage of shifts in the last 30 days were filled by agency staff?"
  • "Beyond the state minimum 8 hours of dementia training, what additional training do your SCU staff receive, Teepa Snow's PAC, Validation Therapy, Music & Memory, Montessori-Based Dementia Programming?"
  • "What percentage of your SCU residents are on a regular antipsychotic medication? What is your protocol for non-pharmacological behavioral intervention before psychotropic prescribing? What is your specific approach to Lewy body or Parkinson's-related dementia residents?"
  • "Have you been cited under § 2600.231 (PCH SCU) or § 2800.231 (ALR SCU) or F744 / F758 / F605 (NF) in your last two surveys?"
  • "What is your end-of-life care policy? Do you contract with hospice? Can residents die in place?"
  • "What discharge triggers will move a resident out of the SCU?"
  • "What is the SCU base rate, the SCU premium over the general unit, what triggers a level-of-care upcharge, and what is included versus billed as ancillary?"
  • "Is the SCU SAGECare-credentialed? Can the SCU accommodate kosher, halal, vegan, or culturally specific diets?"
  • "Does the SCU have an active family council? May I make an unannounced visit on a different day?"

Programming approaches worth recognizing on tour: Eden Alternative (philosophy of long-term care emphasizing elimination of loneliness, helplessness, and boredom; certified Eden Associate credential), Green House Project (small-house residential model often used in NF dementia units), Teepa Snow's Positive Approach to Care (PAC, person-centered methodology with specific communication and behavioral-intervention techniques; certification levels Awareness, Engagement, Skills, Trainer), Validation Therapy (Naomi Feil, validates the resident's emotional reality rather than correcting orientation), Reminiscence Therapy (use of life-history materials to evoke memory and emotional engagement), Music & Memory (501(c)(3) program providing personalized music playlists; certification searchable on musicandmemory.org with documented improvements in mood, agitation, and antipsychotic reduction), and Montessori-Based Dementia Programming (Cameron Camp's methodology of structured purposeful activities matched to remaining abilities).

For NF dementia units, Care Compare gives families a usable signal even though the overall 5-Star rating combines all units in the facility rather than the dementia unit specifically. Drill into the QM domain for the long-stay antipsychotic rate, falls with major injury, pressure ulcer rate, and hospitalization rate. Read the most recent two CMS Form 2567 deficiency statements, looking for F744, F758, F605, F600, F689, F684, or F622 citations. ProPublica Nursing Home Inspect (projects.propublica.org/nursing-homes) gives an easier interface over the same data.

For PCH and ALR SCUs, search PA COMPASS at compass.state.pa.us by facility name and review the most recent two BHSL or OLTL inspection reports. Repeat citations in consecutive cycles are the largest red flag. Look specifically for citations under § 2600.231 / § 2800.231 (SCU subchapter), § 2600.65 / § 2800.65 (training), and § 2600.190 / § 2800.190 (medication administration).

Comparison: PCH SCU vs. ALR SCU vs. NF Dementia Unit vs. LIFE

Dimension PCH SCU ALR SCU NF Dementia Unit LIFE (PACE)
License authority DHS BHSL DHS OLTL DOH DOH (clinic) + federal PACE
Regulation 55 Pa. Code §§ 2600.231–2600.239 55 Pa. Code §§ 2800.231–2800.239 28 Pa. Code Ch. 201/211 + F-tag framework 42 CFR Part 460
Awake staffing Per § 2600.231 Per § 2800.231 1:6 typical (operational) Per CMS PACE standards
Sleep staffing Per § 2600.231 Per § 2800.231 1:10 typical (operational) Per CMS PACE standards
Dementia training Per §§ 2600.231 and 2600.65 Per §§ 2800.231 and 2800.65 (higher baseline than PCH) F744-driven; no state floor Per PACE IDT standards
Aging in place Limited (14-day bedfast cap, no Stage III/IV) Yes (Chapter 2800 mandate + SHCS) Yes (through end of life) Yes (community-based)
Typical 2026 cost $5,500–$8,000/mo $7,500–$10,000+/mo $10,400–$12,800 private; PPL on Medicaid $0 to participant if MA-eligible
Medicaid coverage None (no PA AL waiver) None (no PA AL waiver) Yes (CHC for adults 21+) Yes (capitated MA + Medicare)
Inspection portal PA COMPASS (BHSL) PA COMPASS (OLTL) CMS Care Compare + PA DOH NH Reports PA COMPASS + CMS PACE oversight
~% of PA memory-care beds ~95% ~5% All NF dementia placement ~8,446 total LIFE participants

Where Brevy Comes In

Choosing the right memory-care setting for a parent with dementia is one of the highest-stakes decisions a PA family will ever make, and the regulatory differences between PCH SCU, ALR SCU, and NF dementia unit are the kind of distinction that gets buried in marketing brochures. Brevy is building the most trusted source of PA dementia-care information in the country. If you would like a hand thinking through which setting fits your parent's stage of disease, what funding sources realistically apply, how to read a CMS Care Compare or PA COMPASS inspection report, or how to evaluate a Lewy body antipsychotic protocol, message Polaris or visit brevy.com.

Need help thinking through PCH memory care, ALR memory care, or a nursing facility dementia unit for a parent in PA? Polaris can walk you through the staging, funding, and quality-evaluation steps. Start at brevy.com.

Key 2026 Pennsylvania Memory Care Facts

  • About 282,000 PA residents 65+ have Alzheimer's disease, supported by 472,000 family caregivers contributing ~835 million unpaid hours per year ($17.2B economic value). PA Medicaid spend on Alzheimer's-related care: ~$4.6B/year.
  • PCH SCU and ALR SCU staffing minimums are set by §§ 2600.231 and 2800.231, materially stricter than general PCH and ALR requirements. Dementia training requirements are defined under §§ 2600.65 and 2800.65.
  • PCH memory care typical 2026 cost: $5,500 to $8,000/mo. ALR memory care: $7,500 to $10,000+/mo. NF dementia unit private-pay: $10,400 to $12,800/mo.
  • PA Medicaid: NO coverage for PCH or ALR memory care (no AL waiver). YES coverage for NF dementia unit through CHC for adults 21+ at NF clinical eligibility.
  • Special Income Limit (300% SSI): $2,982/month single. Asset limit (with $6,000 disregard): $8,000. Penalty divisor: $421.20/day. Home equity exemption: $752,000. NF PNA: $60/month (Act 60 of 2024).
  • CSRA range: $32,532 to $162,660. MMNA max: $4,066.50/month effective 1/1/2026.
  • Federal CMS-3442-F minimum staffing rule REPEALED effective 2/2/2026. PA's direct-care staffing floor under 28 Pa. Code Ch. 211 remains binding.
  • Act 111 of 2024 created the PA Alzheimer's, Dementia and Related Disorders (ADRD) Office in PDA. Effective ~4/14/2025. Contact: ADRDoffice@pa.gov, (717) 783-1550.
  • Alzheimer's Association 24/7 Helpline: 1-800-272-3900. PA LTC Ombudsman: 717-783-8975. PA Link/CSP: 1-800-753-8827. PHLP: 1-800-274-3258. Maximus IEB: 1-877-550-4227.

Common Misconceptions

  • "Memory care and assisted living are the same thing." False. Memory care is a clinical and operational designation for dementia-specific care. Assisted living is a license category (the ALR license under 55 Pa. Code Ch. 2800). Memory care can exist inside an ALR, a PCH, or a nursing facility, three different license types under three different bureaus.
  • "Medicaid pays for memory care in Pennsylvania." Overstated and misleading. PA Medicaid pays for NF dementia care through CHC for adults 21+ who meet eligibility. PA Medicaid does NOT pay for PCH SCU or ALR SCU memory care; there is no AL/MC waiver in PA.
  • "All memory care units are secured." False. Pennsylvania regulation only triggers the SCU subchapter when a unit is held out as serving cognitively-impaired residents, controls egress, OR charges differential rates. A facility may market "memory care" without operating a regulated SCU. Always verify by asking for the SCU Disclosure form and confirming the regulatory citation (§ 2600.231 or § 2800.231).
  • "5-Star ratings on Care Compare tell you about dementia quality." Oversimplified. The CMS Five-Star rating combines health-inspection, staffing, and quality-measure domains across the entire facility, not the dementia unit specifically. A 4-Star NF can have a 1-Star dementia unit (or vice versa). Drill into the F-tag history (F744, F758, F605) and the antipsychotic prescribing rate to evaluate dementia-care quality.
  • "Hospice means we're giving up." Misleading. For advanced dementia (FAST 7c+ with comorbid condition), hospice is the appropriate care plan. It improves quality of life, family experience, and outcomes. It is comfort-focused, not the cessation of care.
  • "Antipsychotics are the standard treatment for dementia behaviors." False. Federal F758 and CMS State Operations Manual guidance, plus PA's care framework, require non-pharmacological interventions first. Antipsychotics are reserved for specific clinical indications, with documented Gradual Dose Reduction attempts. Lewy body and Parkinson's-related dementia residents are particularly sensitive and require specialist guidance on which antipsychotic, if any, is appropriate.
  • "Alzheimer's only affects memory." False. Alzheimer's affects a constellation of cognitive functions, memory, language, executive function, visuospatial perception, judgment, and progresses to ADL/IADL impairment, behavioral changes, and motor decline. Care planning that addresses only memory misses the full scope of the disease.
  • "My parent has dementia, so they need memory care now." Overstated. Mild dementia (GDS 3-4) can often be managed at home with adult day, in-home support, GUIDE Model navigation, LIFE enrollment, and family caregiving. Memory care typically becomes appropriate at GDS 5-6 (moderate dementia), driven by safety, caregiver burden, and behavioral acuity rather than diagnosis alone.

Frequently Asked Questions

Is "memory care" a separate license in Pennsylvania?

No. Memory care is a clinical and operational concept, not a license. PA delivers memory care inside one of three already-licensed settings: a PCH with a Secured Dementia Care Unit (55 Pa. Code §§ 2600.231 to 2600.239, licensed by DHS BHSL), an ALR with a Secured Dementia Care Unit (55 Pa. Code §§ 2800.231 to 2800.239, licensed by DHS OLTL), or a nursing facility dementia unit operated within an existing 28 Pa. Code Chapter 201 license issued by DOH. The first question to ask on tour is which underlying license the unit operates under.

Does Pennsylvania Medicaid pay for memory care?

It depends on the setting. PA Medicaid pays for nursing facility dementia care through Community HealthChoices for adults 21+ who meet NF clinical and financial eligibility (Special Income Limit $2,982/month single in 2026, asset limit $8,000 with the $6,000 PA disregard). PA Medicaid does NOT pay for PCH SCU or ALR SCU memory care because PA does not operate an assisted-living Medicaid waiver. The PCHS state supplement helps low-income PCH residents but does not reach memory-care market rates.

What does memory care cost in Pennsylvania in 2026?

PCH memory care runs roughly $5,500 to $8,000 per month statewide ($4,500 to $5,500 base PCH plus $1,000 to $2,500 SCU premium). ALR memory care runs $7,500 to $10,000+ per month ($5,500 to $7,000 base ALR plus $1,000 to $2,500 SCU premium). NF dementia unit private-pay runs $10,400 to $12,800 per month, plus a $500 to $1,500 SCU premium depending on the facility. Southeastern PA runs $1,000 to $3,000 per month above the statewide median; rural PA runs about $1,000 below.

What is the staffing ratio in a PA memory care unit?

PCH SCU and ALR SCU both require enhanced staffing minimums under 55 Pa. Code §§ 2600.231 and 2800.231, materially stricter than general PCH and ALR requirements. NF dementia units have no separate state regulatory ratio but operationally exceed the general 28 Pa. Code Chapter 211 staffing floor because dementia care is acuity-intensive.

How much dementia training do PA memory care staff get?

PCH SCU and ALR SCU staff must complete dementia-specific training before working unsupervised in the SCU and ongoing annual continuing education, under §§ 2600.65 and 2800.65. The highest-quality PA SCUs train substantially above the regulatory minimum, often through Teepa Snow's Positive Approach to Care, Validation Therapy, Music & Memory certification, or Montessori-Based Dementia Programming. NF dementia units have no specific state training floor but operate under the federal F744 quality-of-care standard.

My mom has Lewy body dementia, what should I be careful about in memory care?

This is the single most important dementia-specific safety issue in PA memory care. Lewy body and Parkinson's-related dementia residents are extremely sensitive to typical and many atypical antipsychotic medications; haloperidol, olanzapine, and risperidone can trigger severe neuroleptic sensitivity reactions including muscle rigidity, fever, autonomic instability, and death. Quetiapine (Seroquel) and pimavanserin (Nuplazid, FDA-approved 2016 for Parkinson's psychosis) are the two antipsychotics generally considered acceptable. Confirm with the SCU before admission that staff understand the LBD antipsychotic sensitivity, that the resident's neurology team is in the loop on prescribing decisions, and that the unit's protocol prefers quetiapine or pimavanserin. Monitor for neuroleptic sensitivity reactions in the first one to two weeks after any new antipsychotic.

When should we move my parent into memory care?

Memory care typically becomes appropriate at Reisberg's GDS Stage 5 (moderate dementia), when the person needs help selecting clothing, gets disoriented to place or time, and the home environment can no longer be made safe. The practical triggers are wandering or elopement risk, repeated unattended cooking incidents, medication errors, sundowning that erodes the caregiver's sleep, falls with injury, incontinence beyond family capacity, physical aggression toward a spouse, and resistance to bathing or food and fluids. If disease is stable in early-to-mid stage with adequate in-home support, GUIDE Model navigation, adult day, or LIFE enrollment, home care can often continue safely.

PA's first-ever ADRD Office, created by Act 111 of 2024 and effective approximately April 14, 2025. The office sits within the PA Department of Aging with a $1.9 million initial appropriation and an Advisory Committee, charged with coordinating dementia services across state agencies, AAAs, academic medical centers, advocacy organizations, and consumer representatives, and refreshing the PA Alzheimer's State Plan. Contact: ADRDoffice@pa.gov, (717) 783-1550. The office hosts the Reimagine ADRD Symposium series.

Will my parent's nursing home be able to keep them as their dementia progresses?

In most cases yes. NF dementia units are designed to accommodate end-of-life care and the federal bed-hold rule at 42 CFR § 483.15(e) plus PA Medicaid bed-hold (up to 15 days/year for hospitalization) protect against forced discharge during hospital stays. ALR SCUs operate under Chapter 2800's aging-in-place mandate with Supplemental Health Care Services contracted in, so residents typically remain through end of life via contracted hospice. PCH SCUs are different: the 14-day bedfast cap, Stage III/IV pressure ulcer prohibition, and limit on continuous skilled nursing force PCH SCU residents to transfer to a NF dementia unit as their disease progresses. The transition timing matters and should be discussed with the SCU before placement.

How do I evaluate a PA memory care community?

The most actionable single signal is staff turnover: ask the SCU manager what the SCU staff turnover was in the last 12 months and what percentage of SCU shifts in the last 30 days were filled by agency staff. Industry average is 60 to 80 percent annual turnover; sub-50 percent is exceptional, and high agency utilization (above 20 percent) is a red flag. Pull the inspection history (PA COMPASS for PCH/ALR SCUs at compass.state.pa.us; CMS Care Compare for NF dementia units at medicare.gov/care-compare). For NF dementia units, drill into the QM domain for long-stay antipsychotic rate, falls with major injury, pressure ulcers, and hospitalization rate. Tour at least two facilities, request the SCU Disclosure form before signing, ask the full tour-question list above, and consider an unannounced visit on a different day.

Where to Go Next

Find personalized help navigating Pennsylvania memory care options at brevy.com.

BC

Brevy Care Team

Expert eldercare guidance from Brevy's team of healthcare professionals and researchers.